Shop

Description

Overview

• Dotarem® (gadoterate meglumine) is a well-established macrocyclic gadolinium-based contrast agent offered by BPL Technologies.
• Developed with a focus on maximum molecular stability to ensure safety and reliability during MRI procedures.
• Designed by Guerbet’s research team, providing a high clinical legacy and trusted use in radiology.
• Supports patient safety across a wide range of MRI applications by minimizing the risk of gadolinium release.

Key Features

• Macrocyclic Molecular Structure: Provides maximum stability and reduced risk of gadolinium release.
• Trusted Clinical Legacy: Established safety and efficacy profile in multiple MRI applications.
• Wide MRI Applicability: Suitable for a broad range of diagnostic imaging procedures.
• Patient Safety Focused: Designed to minimize potential adverse effects associated with contrast agents.

Clinical Applications

• Magnetic Resonance Imaging (MRI) of brain, spine, and body organs
• Assessment of vascular structures and pathology
• Detection and characterization of lesions and tumors
• Pre- and post-operative imaging for surgical planning
• Enhanced imaging in routine and advanced diagnostic protocols

Clinical Benefits

• Reliable and safe contrast enhancement for high-quality MRI imaging
• Reduced risk of gadolinium deposition due to stable molecular design
• Consistent imaging performance across a variety of MRI applications
• Supports confident diagnosis and clinical decision-making
• Trusted by clinicians with decades of documented use